BERRA, MAURO
BERRA, MAURO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation
2009 S. Varchetta, B. Oliviero, M. Francesca Donato, F. Agnelli, C. Rigamonti, E. Paudice, E. Arosio, M. Berra, G. Rossi, C. Tinelli, F.F. Fagnoni, M. Colombo, D. Mavilio, M.U. Mondelli
Late graft dysfunction (GD) in HBV recurrence-free recipients is associated with serum antinuclear antibodies (ANA) reactivity
2007 M.F. Donato, E. Arosio, V. Monti, F. Agnelli, C. Rigamonti, M. Berra, M. Viganò, G. Rossi, M. Colombo
Serum nuclear autoantibodies with nucleolar pattern in chronic liver diseases
2006 V. Monti, E. Arosio, M.F. Donato, M. Berra, A. Aghemo, M. Colombo
Prevalence of serum antinuclear antibodies (ANA) after liver transplant in HCV and HBV recipients is associated with different clinical profiles
2006 M.F. Donato, E. Arosio, V. Monti, F. Agnelli, C. Rigamonti, M. Berra, M. Colombo
Serum nuclear autoantibodies with nucleolar pattern in chronic liver diseases
2006 V. Monti, E. Arosio, M.F. Donato, M. Berra, A. Aghemo, V. Carbonelli, M. Colombo
Serum antinuclear antibodies (ANA) in HCV-related cirrhosis: correlation with liver cell proliferation status and hepatocellular carcinoma (HCC) development
2006 E. Arosio, M. Donato, V. Monti, M. Berra, M. Balestrieri, G. Ronchi, M. Colombo
Serum autoantibodies correlates with severity of hepatitis c recurrence after liver transplant
2006 M. Donato, E. Arosio, V. Monti, M. Berra, F. Agnelli, C. Rigamonti, G. Rossi, M. Colombo